← Home
📢 Press Releases
| Date | Press release |
|---|---|
| 2026-06-11 07:00:00 | Syndax Announces Publication Of Save Data On Revuforj® (revumenib) In Combination With Decitabine/cedazuridine And Venetoclax In Relapsed/refractory Npm1m, Kmt2ar, And Nup98r Aml In The Journal Of Clinical Oncology – high response rates observed with the all-oral combination in a heavily pretreated population, including 88% (37/42) orr, 71% (30/42) crc, and 60% cr/crh (25/42) – – strong activity across subgroups, including 70% (14/20) cr/crh in venetoclax-naÏve and 50% (11/22) cr/crh in venetoclax-exposed patients – – deep responses with 80% (24/30) mrd negativity among evaluable crc responders – – robust transplant rate with 45% (19/42) of patients proceeding to transplant and 63% (12/19) resuming revumenib post-transplant – – encouraging durability with median overall survival after transplant not reached – – combination was generally well-tolerated – new york, june 11, 2026 (globe newswire) -- syndax pharmaceuticals (nasdaq: sndx), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that data from the phase 1/2 save trial of an all-oral regimen of revuforj® (revumenib), decitabine/cedazuridine, and venetoclax in relapsed or refractory (r/r) npm1 mutated (npm1m), kmt2a-rearranged (kmt2ar), or nup98-rearranged (nup98r) acute myeloid leukemia (aml) were published in the journal of clinical oncology and simultaneously presented at the european hematology association (eha) 2026 congress in stockholm, sweden. revuforj is the first and only menin inhibitor that is fda approved for patients one year and older with r/r aml with a susceptible npm1 mutation who have no satisfactory alternative treatment options or r/r acute leukemia with a kmt2a translocation as determined by an fda-authorized test. |
| 2026-05-29 08:30:00 | Kennametal Strengthens Balance Sheet & Enhances Liquidity Actions extend debt maturities, preserve financial flexibility and support growth opportunities raised additional $700 million liquidity through new 3-year term loan and expansion of existing revolving credit facility additional liquidity supports near-term tungsten related working capital needs while preserving long-term flexibility refinanced $300 million in bonds, extending maturities to 2036, as previously reported transactions consistent with maintained investment grade credit rating profile pittsburgh, may 29, 2026 /prnewswire/ -- kennametal inc. (nyse: kmt) (the ’company’) today announced a series of financing transactions designed to enhance liquidity, extend debt maturities and position the company to capture near-term growth opportunities. the actions provide additional financial flexibility to support near-term tungsten related working capital needs while preserving flexibility to respond to future market developments. |
| 2026-05-27 06:45:00 | Kennametal Inc. Announces Final Results And Expiration Of Cash Tender Offer For Debt Securities Pittsburgh, may 27, 2026 /prnewswire/ -- kennametal inc. (nyse: kmt) (the ’company’) today announced the final results and expiration of its previously announced cash tender offer (the ’tender offer’) to purchase any and all of the outstanding notes listed in the table below (the ’notes’). capitalized terms used in this news release and not defined herein have the meanings given to them in the offer to purchase, dated may 19, 2026 (the ’offer to purchase’). |
| 2026-05-26 15:25:00 | Kennametal Inc. Announces Pricing Terms Of Cash Tender Offer For Debt Securities Pittsburgh, may 26, 2026 /prnewswire/ -- kennametal inc. (nyse: kmt) (the ’company’) today announced the pricing terms of its previously announced cash tender offer (the ’tender offer’) to purchase any and all of its outstanding 4.625% senior notes due 2028 (the ’2028 notes’). all other terms and conditions of the tender offer remain unchanged and are described in the offer to purchase, dated may 19, 2026 (the ’offer to purchase’). |
| 2026-05-19 09:15:00 | Kennametal Inc. Announces Public Offering Of Senior Notes And Cash Tender Offer For Debt Securities Pittsburgh, may 19, 2026 /prnewswire/ -- kennametal inc. (nyse: kmt) (the ’company’) today announced that it has commenced an underwritten public offering of senior notes (the ’notes offering’). the exact amount and terms of the notes offering will depend upon market conditions and other factors. |
| 2026-05-18 13:00:00 |
|
| 2026-05-06 06:30:00 |
|
| 2026-04-22 07:00:00 |
|
| 2026-04-15 06:30:00 |
|
| 2026-03-09 10:39:00 |
|
| 2026-02-24 08:03:00 |
|
| 2026-02-24 06:30:00 |
|
| 2026-02-17 06:30:00 |
|
| 2026-02-04 06:30:00 |
|
| 2026-01-28 06:30:00 |
|
📰 Browse additional press releases for Kennametal!
Sign up for free or log in📘 Claim your free eBook: "The Checklist Value Investor — A Smarter Way to Pick Stocks"